Brind.

GoodRx stock underperformed the S&P 500 composite on August 7, 2025.

1 report, 1 independent Updated Aug 7
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

GoodRx stock underperformed the S&P 500 composite on August 7, 2025.

Who's involved

What this event is mainly about
GoodRx

Keep exploring

The entities involved

  • GoodRx

    American prescription drug price tracking website and app

    Nothing else this week.

Related events

Coverage

Newest first; wire copies grouped
  • ZacksCompared to Estimates, GoodRx (GDRX) Q2 Earnings: A Look at Key Metrics For the quarter ended June 2025, GoodRx Holdings, Inc. (GDRX) reported revenue of $203.07 million, up 1.2% over the same period